

Apert syndrome: modern aspects of diagnosis and treatment
https://doi.org/10.21508/1027-4065-2024-69-2-107-116
Abstract
The purpose of this review is to raise awareness of medical professionals about the features of the clinical picture, the possibilities of diagnosis (including prenatal) and therapy of patients with Apert syndrome to further improve the prognosis and improve the quality of life. Acrocephalosyndactyly is a group of rare congenital syndromes characterized by the presence of acrocephaly, craniofacial anomalies, syndactyly of the hands and feet. According to the literature, the most common form of аcrocephalosyndactyly is Apert syndrome (acrocephalosyndactyly type I, Apert syndrome, ICD 10 Q 87.0, OMIM 101200). This is a genetic disease inherited by an autosomal dominant type. CA is caused by a mutation of the fibroblast growth factor receptor type 2 gene (FGFR2) located on the long arm of chromosome 10, which leads to increased bone metabolism and impaired bone synthesis. The frequency of Apert syndrome is about 15 cases per 1,000,000 live births. Wheaton first reported this pathology in 1894, and in 1906 the French pediatrician Eugene Apert published a series of nine clinical cases with a characteristic triad of symptoms. Apert syndrome is characterized by craniosynostosis, bilateral symmetrical limb syndactyly and dysmorphic facial features. Hypoplasia of the upper jaw and bicoronal synostosis are two noticeable craniofacial defects that lead to a flat, deepened appearance of the forehead and the middle part of the face. Hypertelorism and excessive orbitality, low-set ears, flat nose and cleft palate are often found. Cardiovascular, neurological and genitourinary abnormalities may be present. Diagnosis is based on clinical criteria and molecular genetic testing. There is a possibility of prenatal detection of Apert syndrome.
About the Authors
S. S. KantutisRussian Federation
Moscow
E. A. Sarkisyan
Russian Federation
Moscow
P. V. Shumilov
Russian Federation
Moscow
L. D. Vorona
Russian Federation
Moscow
O. V. Pravoslavnaya
Russian Federation
Moscow
L. A. Levchenko
Russian Federation
Moscow
E. I. Shabelnikova
Russian Federation
Moscow
M. A. Sokolova
Russian Federation
Moscow
A. I. Krapivkin
Russian Federation
Moscow
References
1. Kajdic N., Spazzapan P., Velnar T. Craniosynostosis — Recognition, clinical characteristics, and treatment. Bosn J Basic Med Sci 2018; 18(2): 110–116. DOI: 10.17305/bjbms.2017.2083
2. Armand T., Schaefer E., Di Rocco F., Edery P., Collet C., Rossi M. Genetic bases of craniosynostoses: An update. Neurochirurgie 2019; 65(5): 196–201. DOI: 10.1016/j.neuchi.2019.10.003
3. Yasonov S.A. Syndromic craniosynostoses: the main clinical manifestations and modern possibilities of rehabilitation. Rare pathology in pediatrics. Pediatriya 2012; 91(5): 108–116. (in Russ.)
4. Al-Namnam N.M., Jayash S.N., Hariri F., Rahman Z.A.A., Alshawsh M.A. Insights and future directions of potential genetic therapy for Apert syndrome: A systematic review. Gene Ther 2021; 28: 620–633. DOI: 10.1038/s41434–021–00238-w
5. Tan A.P., Mankad K. Apert syndrome: magnetic resonance imaging (MRI) of associated intracranial anomalies. Childs Nerv Syst 2018; 34(2): 205–216. DOI: 10.1007/s00381–017–3670–0
6. Partoune S., Masereel M.C. Casclinique. Le syndrome d’Apert: acrocéphalosyndactilie de type I [Apert syndrome or acrocephalosyndactilia type I. Rev Med Liege 2021; 76(10): 715–718. French. PMID: 34632738
7. Benmiloud S., Chaouki S., Atmani S., Hida M. Le syndrome d’apert [Apert syndrome. Pan Afr Med J 2013; 14: 66. French. DOI: 10.11604/pamj.2013.14.66.2178
8. Freiman A., Tessler O., Barankin B. Apert syndrome. Int J Dermatol. 2006; 45(11): 1341–1343. DOI: 10.1111/j.1365–4632.2006.02745.x. PMID: 17076721
9. Azoury S.C., Reddy S., Shukla V., Deng C.X. Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis. Int J Biol Sci 2017; 13(12): 1479–1488. DOI: 10.7150/ijbs.22373
10. Ludwig K., Salmaso R., Manara R., Cosmi E., Baldi M., Rugge M. Apert syndrome with fused thalami. Fetal PediatrPathol 2012; 31(6): 410–414. DOI: 10.3109/15513815.2012.659407
11. Yasonov S.A., Lopatin A.V., Maslov V.V., Vasiliev I.G., Bystrov A.V. Aper Syndrome: modernpossibilities of complex reconstructive treatment. Detskaya bol’nitsa 2011; 2: 51–54. (in Russ.)
12. Shvedovchenko I.V., Bardas A.A., Minkin A.V., Koltsov A.A. The current view of views acrocephalosyndactyly in children (a review of literature). Genii Ortopedii 2013; 2: 90–97. (in Russ.)
13. Benmiloud S., Chaouki S., Atmani S., Hida M. Apert syndrome. Pan Afr Med J 2013; 14: 66. French. DOI: 10.11604/pamj.2013.14.66.2178
14. Yaghoobi R., Bagherani N., Tajalli M., Paziar N. Apert syndrome. Indian J Dermatol Venereol Leprol 2010; 76(6): 724. DOI: 10.4103/0378–6323.72479
15. Wenger T.L., Hing A.V., Evans K.N. Apert Syndrome. 2019 https://www.ncbi.nlm.nih.gov/books/NBK541728 / Ссылка активна на 27.02.2024.
16. Klimov L.Ya., Vdovina T.M., Kuryaninova V.A., Pisisova N.N., Dolbnya S.V., Stoyan M.V. et al. The case of Apert’s syndrome in the girl. Meditsinskii vestnik Severnogo Kavkaza 2012; 4: 98–101. (in Russ.)
17. Belopasov V.V., Tkacheva N.V., Soprunova I.V. Acrocephalosyndactyly type I (Aper syndrome). Russkii zhurnal detskoi nevrologii 2009; 4(4): 48–50. (in Russ.)
18. Avery’s Diseases of the Newborn, 11th Edition. Edited by Christine A. Gleason, 2023; 1849–1852
19. Koltunov D.E., Belchenko V.A. Characteristics of skeletal deformities in patients with Apert, Cruson, Pfeiffer syndrome. Voprosy prakticheskoi pediatrii 2012; 7(6): 57–62. (in Russ.)
20. Koca T.T. Apert syndrome: A case report and review of the literature. North ClinIstanb 2016; 3(2): 135–139. DOI: 10.14744/nci.2015.30602
21. Wenger T., Miller D., Evans K. FGFR Craniosynostosis Syndromes Overview https://www.ncbi.nlm.nih.gov/books/NBK1455 / Ссылка активна на 27.02.2024.
22. Calis M., Oznur A., Ekin O., Vargel I. Correction of Brachymetatarsia and Medial Angulation of the Great Toe of Apert Foot By Distraction Osteogenesis: A Review of 7 Years of Experience. J Pediatr Orthop 2016; 36(6): 582–528. DOI: 10.1097/BPO.0000000000000503
23. DalbenGda S., das Neves L.T., Gomide M.R. Oral findings in patients with Apert syndrome. J Appl Oral Sci 2006; 14(6): 465–469. DOI: 10.1590/s1678–77572006000600014
24. Khong J.J., Anderson P., Gray T.L., Hammerton M., Selva D., David D. Ophthalmic findings in Apert’s syndrome after craniofacial surgery: twenty-nine years’ experience. Ophthalmology 2006; 113(2): 347–352. DOI: 10.1016/j.ophtha.2005.10.011
25. Agochukwu N.B., Solomon B.D., Muenke M. Hearing loss in syndromic craniosynostoses: otologic manifestations and clinical findings. Int J Pediatr Otorhinolaryngol 2014; 78(12): 2037–2047. DOI: 10.1016/j.ijporl.2014.09.019
26. Wenger T.L., Hopper R.A., Rosen A., Tully H.M., Cunningham M.L., Lee A. A genotype-specific surgical approach for patients with Pfeiffer syndrome due to W290C pathogenic variant in FGFR2 is associated with improved developmental outcomes and reduced mortality. Genet Med 2019; 21(2): 471–476. DOI: 10.1038/s41436–018–0073-x
27. Koltunov D.E., Belchenko V.A. Diagnosis of syndromic forms of craniosynostoses. Voprosy prakticheskou pediatrii 2013; 8(3): 52–55. (in Russ.)
28. Das S., Munshi A. Research advances in Apert syndrome. J Oral Biol Craniofac Res 2018; 8(3): 194–199. DOI: 10.1016/j.jobcr.2017.05.006
29. Vieira C., Teixeira N., Cadilhe A., Reis I. Apert syndrome: prenatal diagnosis challenge. BMJ Case Rep 2019; 12(12): e231982. DOI: 10.1136/bcr-2019–231982
Review
For citations:
Kantutis S.S., Sarkisyan E.A., Shumilov P.V., Vorona L.D., Pravoslavnaya O.V., Levchenko L.A., Shabelnikova E.I., Sokolova M.A., Krapivkin A.I. Apert syndrome: modern aspects of diagnosis and treatment. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2024;69(2):107-116. (In Russ.) https://doi.org/10.21508/1027-4065-2024-69-2-107-116